Skip to main content
  • 9 Accesses

Abstract

How have the less developed nations fared in the process of spatial diffusion? Have they suffered in terms of arrival time lags and availability of Pharmaceuticals? Before attempting to answer these and other related questions some definitions are necessary. In particular it is important to identify those countries that come within the less developed category. Table 6.1 will help.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Notes

  1. See J. E. S. Parker, The Economics of Innovation: the National and multinational Enterprise in Technological change, 2nd edn, Longman, 1978.

    Google Scholar 

  2. Henry G. Grabowski, ‘Regulation and the International Diffusion of Pharmaceuticals’ in Robert B. Holms (ed.), The International Supply of Medicine, American Enterprise Institute, 1980.

    Google Scholar 

Download references

Authors

Copyright information

© 1984 J. E. S. Parker

About this chapter

Cite this chapter

Parker, J.E.S. (1984). Less Developed Nations. In: The International Diffusion of Pharmaceuticals. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-06599-8_6

Download citation

Publish with us

Policies and ethics